Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Ironwood Pharmaceuticals, Inc. (IRWD) had Debt to Capital Ratio of 3.19 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$122.06M |
|
$40.08M |
|
-- |
|
$122.06M |
|
$46.58M |
|
$75.48M |
|
$-7.46M |
|
$68.02M |
|
$68.02M |
|
$40.08M |
|
$40.08M |
|
$40.08M |
|
$40.08M |
|
$75.48M |
|
$75.96M |
|
162.22M |
|
177.76M |
|
$0.25 |
|
$0.23 |
|
| Balance Sheet Financials | |
$273.84M |
|
$3.67M |
|
$122.22M |
|
$396.06M |
|
$242.50M |
|
$385.00M |
|
$417.72M |
|
$660.22M |
|
$-264.16M |
|
$-266.40M |
|
$-264.16M |
|
162.68M |
|
| Cash Flow Statement Financials | |
$52.47M |
|
$-0.04M |
|
$0.09M |
|
$88.56M |
|
$140.41M |
|
$51.85M |
|
$13.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.13 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
3.19 |
-2.21 |
|
100.00% |
|
61.84% |
|
61.84% |
|
-- |
|
55.73% |
|
32.84% |
|
$52.43M |
|
-- |
|
-- |
|
-- |
|
0.31 |
|
-- |
|
1.01 |
|
88.75 |
|
-15.17% |
|
-15.04% |
|
10.12% |
|
33.17% |
|
$-1.62 |
|
$0.29 |
|
$0.30 |
|